Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Sequential Clinical Trial of Sodium Valproate in ALS
NCT00136110 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Sequential Clinical Trial of Sodium Valproate in ALS
- Lead sponsor
- UMC Utrecht
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 2005
- Completion date
- February 28, 2007
- Enrollment
- 165 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.